Related Experiment Videos
Renal replacement therapy and acute renal failure
1Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA. albert.quan@utsouthwestern.edu
Current Opinion in Pediatrics
|April 1, 2005
Summary
New advancements in renal replacement therapies offer improved management for acute renal failure (ARF). Early initiation of dialysis and exploring novel options can enhance patient survival and outcomes in ARF.
Area of Science:
- Nephrology
- Critical Care Medicine
Background:
- Acute renal failure (ARF) is characterized by a rapid decrease in glomerular filtration rate.
- Effective management of ARF is crucial for patient outcomes.
Purpose of the Study:
- To review emerging developments and clinical uses of renal replacement therapies for ARF.
- To explore hemodialysis, continuous renal replacement therapy, bioartificial kidney, and peritoneal dialysis.
Main Methods:
- Review of recent literature on renal replacement therapies.
- Analysis of new technologies and clinical trial data.
Main Results:
- Hemodialysis innovations include in-line hematocrit monitoring and advanced dialyzer membranes.
- Increased dialysis delivery shows improved outcomes, but optimal regimens (intermittent vs. continuous) require further study.
- The bioartificial kidney is in clinical trials; peritoneal dialysis is exploring new solutions like icodextrin.
Conclusions:
- Optimal renal replacement therapy selection is multifactorial.
- New therapeutic options and early dialysis initiation may improve ARF patient survival and outcomes.